Neonatal diabetes mellitus

ISSN 1662-4009 (online)

An indispensable reference tool endorsed by the European Society for Paediatric Endocrinology

Previous issue | Volume 19 | ESPEYB19 | Next issue

Yearbook of Paediatric Endocrinology 2022

2. Antenatal and Neonatal Endocrinology

Previous section
Neonatal hypoglycaemia

Table of contents

Next section
Gestational Diabetes Mellitus: Neonatal and Long-term Consequences

ey0019.2-9 | Neonatal diabetes mellitus

2.9. SGLT2 inhibitors therapy protects glucotoxicity-induced [beta]-cell failure in a mouse model of human KATP-induced diabetes through mitigation of oxidative and ER stress

ey0019.2-10 | Neonatal diabetes mellitus

2.10. Genetic reduction of glucose metabolism preserves functional [beta]-cell mass in KATP-induced neonatal diabetes

ey0019.2-11 | Neonatal diabetes mellitus

2.11. Cognitive deficits and impaired hippocampal long-term potentiation in KATP-induced DEND syndrome

ey0019.2-12 | Neonatal diabetes mellitus

2.12. Developmental defects and impaired network excitability in a cerebral organoid model of KCNJ11 p.V59M-related neonatal diabetes

ey0019.2-13 | Neonatal diabetes mellitus

2.13. An induced pluripotent stem cell line derived from a patient with neonatal diabetes and Fanconi-Bickel syndrome caused by a homozygous mutation in the SLC2A2 gene

ey0019.2-14 | Neonatal diabetes mellitus

2.14. Mutations and variants of ONECUT1 in diabetes

ESPE Yearbook of Paediatric Endocrinology
ISSN 1662-4009 (Online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more

ESPE Yearbook of Paediatric Endocrinology